Posted: January 21, 2014 at 3:44 am
UCLA Scientists Will Test Drug to Block Stem Cells Leading to Cancer
Scientists from UCLA #39;s Jonsson Comprehensive Cancer Center, led by pioneering cancer researchers Drs. Dennis Slamon and Zev Wainberg, are bringing stem cell ...
By: UCLAJCCC
Go here to see the original:
UCLA Scientists Will Test Drug to Block Stem Cells Leading to Cancer - Video
Posted: January 20, 2014 at 10:49 pm
Stem Cells Anti-Aging Study - Caleb #39;s testimonial after 6 ESC injections
http://a1stemcells.com/anti-aging-2 testimony of Caleb, 36yo, recorded during his 7th injection. It changed Caleb #39;s life. Stem cell rejuvenation program in M...
By: Cure4Cancers
Read more:
Stem Cells Anti-Aging Study - Caleb's testimonial after 6 ESC injections - Video
Posted: January 20, 2014 at 10:49 pm
San Jose, California (PRWEB) January 20, 2014
Follow us on LinkedIn Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal, driving tumorigenesis. Fuelled by the need for more effective treatment options and growing focus of the medical community to develop drugs and therapies that target tumor roots, research in the field of Cancer Stem Cells (CSCs) is attracting increased investments. Stem cells also known as progenitor cells, represent cells that are capable of regenerating malignant tumor cells and thus are responsible for the spread of cancer. As a key cause for tumor recurrence, metastasis, and resistance, cancer stem cells are therefore an important theme for R&D, especially as a drug target. The coming years are forecast to witness the development of novel drugs that target cancer stem cells (CSCs). Research efforts concerning CSCs would be focused on development of in vitro and in vivo methods for identification of CSCs and related biomarkers that would help understand the principles of tumour development and metastasis. Growing demand for effective and accurate cancer detection methodologies against the backdrop of rising cancer incidence is forecast to boost market prospects in the coming years.
The trend report titled Cancer Stem Cells announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the product, its applications, future prospects, and corporate initiatives of key companies worldwide. Also covered are companies such as Boston Biomedical Inc., Macrogenics, and Verastem, Inc.
For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=141066
About Global Industry Analysts, Inc. Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc. Telephone: 408-528-9966 Fax: 408-528-9977 Email: press(at)StrategyR(dot)com Web Site: http://www.StrategyR.com/
###
Go here to see the original:
Rising Prevalence of Cancer Drives the Market for Cancer Stem Cells, According to a New Trend Report Published by ...
Posted: January 20, 2014 at 10:49 pm
Umbilical cord stem cell banking can be expensive and controversial, but Jamie and Ben Page decided to bank their daughter, Harlow's stem cells just in case.
"We had heard about cord blood banking and talked about it a lot and thought let's just go for it and have it just as a backup," Jamie Page said.
They did need it. Harlow had cancer in her uterus.
"On the ultrasound they immediately saw that there was a mass in her abdomen about the size of a grapefruit," Page said.
After a year of chemo, the tumor was gone. Doctors wanted to keep it that way.
"So, when the doctors found out we actually had her own stem cells, they were very excited," Page said.
Oncologist Elaine Morgan says those stem cells helped Harlow.
"I think that her umbilical cord cells were used as a boost to her own cells when we harvested her to have adequate cells for reconstitution," Dr. Morgan said.
Dr. Morgan does not advocate private cord stem cell banking at birth to be saved for a healthy baby's later use, because it's not clinically useful and it's expensive.
The Pages paid almost $2,000 for the initial banking fee, plus an extra $125 per year.
Read more here:
The Practicing Parent: Pros & cons of stem cell banking
Posted: January 20, 2014 at 10:49 pm
Lady's own stem cells heal knee Lady's own stem cells heal knee
Updated: Monday, January 20 2014 2:36 AM EST2014-01-20 07:36:02 GMT
Updated: Sunday, January 19 2014 5:00 PM EST2014-01-19 22:00:19 GMT
Updated: Sunday, January 19 2014 9:00 AM EST2014-01-19 14:00:13 GMT
Updated: Saturday, January 18 2014 11:00 AM EST2014-01-18 16:00:12 GMT
Updated: Saturday, January 18 2014 2:30 AM EST2014-01-18 07:30:46 GMT
CLEARWATER, FL (WFLA/NBC) - When Judy Loar, 68, could not bear to walk any longer due to excruciating pain in both of her knees from degenerative joint disease, she did what most people in her condition do, she went in for a surgical knee replacement.
After being released, Loar found out her knee cap had been set incorrectly.
Going through surgery again to fix her other knee was not an option, so Loar started researching other alternatives to ease the agony of bone-on-bone friction caused by her condition.
"I really did my research, because I knew I could go through another major surgery," said Loar, who became a patient of Dr. Dennis Lox.
See the article here:
Lady's own stem cells heal knee
Posted: January 20, 2014 at 10:49 pm
Paper submissions to "Journal of Regenerative Medicine" can be submitted as an email attachment at contact.scitechnol@scitechnol.com or through EM System.
Suspended Life - Stem Cells: Are Treatments Possible?
The aim of this meeting, organized by the Italian no-profit associations Stampa Rossobl, Sicilia Risvegli Onlus, Niemann Pick Onlus, Omphalos, Organizzazione Sindrome di Angelman (Or.S.A.), Cancellautismo, Marco e Andrea Tremante Foundation, was to confer regarding todays state-of-the-art and novel findings on stem cell research and applications in Italy. The meeting was held in the city of Grottammare Ascoli Piceno County, under the auspices of Luigi Merlo, the Major of the city, and Piero Celani, the County President.
Stem Cell Therapy for Diabetes: A Call for Efficient Differentiation of Pancreatic Progenitors
Given the capacity of differentiating into functional beta cells in vivo, transplantation of pancreatic progenitors derived from human embryonic stem cells (hESCs) has been considered as a promising avenue in beta cell replacement therapy . Besides the concerns of preventing teratoma formation, reducing host immune system rejection and other related safety issues , generating sufficient number of pancreatic progenitors is one of the priorities before any consideration of clinical application.
Use of Immortalized Differentiated Cells for Regenerative Medicine
Stem cells are touted to offer a potential avenue for curing many conditions such as diabetes, cardiovascular disease and Alzheimers disease. The comments raised were of particular significance in regards hurdles for the use of stem cells in regenerative medicine. These include in vivo issues such as cellular survival, senescence, proliferative capacity and differentiation into a functional tissue.
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/ Regeneration - Preclinical Aspects
There is growing evidence showing the promise of mesenchymal stromal cells (MSCs) for the treatment of cutaneous wound healing. In a previous study, we have shown that MSCs seeded on an artificial dermal matrix, Integra enriched with platelet rich plasma (EmatrixTM) have enhanced proliferative potential as compared to those cultured on the scaffold alone. In this study, we wanted to extend the experimentation by evaluating the efficacy of the MSCs bioengineered scaffolds in the healing of skin wounds. To this purpose, full-thickness skin defects were created on the dorsum of rats and covered with (a) Integra, (b) EmatrixTM , (c) Integra plus MSCs, (d) and EmatrixTM plus MSCs, or (e) left to heal spontaneously (control). It was found that the presence of MSCs within the scaffolds significantly accelerated wound healing and greatly ameliorated the quality of regenerated skin; it reduced collagen deposition, enhanced re-epithelization, increased neo-angiogenesis and promoted a greater return of hair follicles and sebaceous glands. In conclusion, the results of this study provide strong evidence that the treatment with MSC-seeded scaffolds represents an attractive approach for augmenting the regenerative potential and enhancing cutaneous wound healing.
Stem Cell Extracellular Matrix Interactions in Three- Dimensional System via Integrins
Posted: January 20, 2014 at 10:44 pm
(WFLA) When Judy Loar, 68, could not bear to walk any longer due to excruciating pain in both of her knees from degenerative joint disease, she did what most people in her condition do, she went in for a surgical knee replacement.
After being released, Loar found out her knee cap had been set incorrectly.
Going through surgery again to fix her other knee was not an option, so Loar started researching other alternatives to ease the agony of bone-on-bone friction caused by her condition.
"I really did my research, because I knew I could go through another major surgery," said Loar who became a patient of Dr. Dennis Lox.
Dr. Lox is the founder and medical director of Tampa-based Florida Spine and Sports Medicine Center, and one of the world's leading doctors specializing in using stem cell therapy as an alternative to successfully treat debilitating injuries or conditions.
Loar describes the procedure as painless, with no down time.
Read More: http://bit.ly/1awatpY
Continue reading here:
More Local News
Posted: January 20, 2014 at 4:47 am
AS Antonia Arnega, a strong bet for embryonic stem cells research
More videos at http://www.andalusianstories.com Antonia Arnega is a researcher born in Granada who decided to leave her specialization in Pediatrics to comp...
By: Andalusian Stories
The rest is here:
AS Antonia Aránega, a strong bet for embryonic stem cells research - Video
Posted: January 20, 2014 at 4:47 am
Stem Cells Anti-Aging Study - Caleb #39;s testimonial after 6 ESC injections
http://a1stemcells.com/anti-aging-2 testimony of Caleb, 36yo, recorded during his 7th injection. It changed Caleb #39;s life. Stem cell rejuvenation program in M...
By: Cure4Cancers
View original post here:
Stem Cells Anti-Aging Study - Caleb's testimonial after 6 ESC injections - Video
Posted: January 18, 2014 at 5:48 pm
ROCHESTER, Minn., Jan. 17 (UPI) -- The U.S. Food and Drug Administration approved a clinical trial of heart failure patients to determine if using stem cells improves the heart, researchers say.
Dr. Andre Terzic, director of the Mayo Clinic's Center for Regenerative Medicine in Rochester, Minn., said the decade-long project using stem cells to repair -- "cure" -- damaged heart tissue could have implications for millions of Americans with heart disease.
The trial is scheduled to involve 240 heart failure patients from 40 hospitals in Europe and Israel.
The procedure could be a "paradigm shift" in the treatment of heart disease, Terzic told the (Minneapolis) Star Tribune.
The process, developed in collaborations with Cardio3 BioSciences of Belgium, involves harvesting stem cells from a patient's bone marrow in the hip, directing the cells to become "cardiopoietic" repair cells, then injecting them back into the heart to repair heart damage.
Dr. Atta Behfar, a researcher on Terzic's team, isolated hundreds of proteins involved in the transcription process that takes place when stem cells are converted to heart cells and identified eight proteins crucial to the process.
Early results are expected in 2015.
Read more:
Mayo Clinic to test adult stem cells to treat heart failure
